Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine 8mg + CPC 2mg vs Lidocaine 1mg + CPC 2mg for Sore Throat
NCT01265446Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in pharyngitis, sponsored by Novartis. Started Dec 2010; status: completed.
02
Drugs
lidocaine
03
Conditions
pharyngitis
Beyond the preview
Go deeper on NCT01265446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265446.